Evolution of Deep Brain Stimulation: Human Electrometer and Smart Devices Supporting the Next Generation of Therapy.
Deep Brain Stimulation (DBS) provides therapeutic benefit for several neuropathologies including Parkinson's disease (PD), epilepsy, chronic pain, and depression. Despite well established clinical efficacy, the mechanism(s) of DBS remains poorly understood. In this review we begin by summarizing the current understanding of the DBS mechanism. Using this knowledge as a framework, we then explore a specific hypothesis regarding DBS of the subthalamic nucleus (STN) for the treatment of PD. This hypothesis states that therapeutic benefit is provided, at least in part, by activation of surviving nigrostriatal dopaminergic neurons, subsequent striatal dopamine release, and resumption of striatal target cell control by dopamine. While highly controversial, we present preliminary data that are consistent with specific predications testing this hypothesis. We additionally propose that developing new technologies, e.g., human electrometer and closed-loop smart devices, for monitoring dopaminergic neurotransmission during STN DBS will further advance this treatment approach.
Lee
Kendall H
KH
Department of Neurosurgery and Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
Blaha
Charles D
CD
Garris
Paul A
PA
Mohseni
Pedram
P
Horne
April E
AE
Bennet
Kevin E
KE
Agnesi
Filippo
F
Bledsoe
Jonathan M
JM
Lester
Deranda B
DB
Kimble
Chris
C
Min
Hoon-Ki
HK
Kim
Young-Bo
YB
Cho
Zang-Hee
ZH